I wrote on May 29 about my worry regarding a dry, flaky patch of skin on my nose. Unsure of the status of this unusual spot, I immediately called my dermatologist and made an appointment -- which did not end up being all that immediate. The earliest slot available for addressing my personal crisis was June 12 at 11 AM. I took it. And then the stars aligned and I got a call on this very same day.

"We have a cancellation tomorrow. Do you want to come in then?" said the voice on the other end of the phone. Yes, yes, yes, I wanted it. And so I took this slot instead.

Yesterday I met with my dermatologist. The good news is: what I found on the bridge of my nose is not cancer. The bad news is: it was trying really hard to become cancer.

In 2006, 174,470 people will be diagnosed with lung cancer in the United States. About 92,700 men and 81,770 women will develop the disease -- the leading cause of cancer death among both men and women.

An estimated 162,460 men and women will die of lung cancer this year, accounting for 28 percent of all cancer deaths and taking more lives than colon, breast, and prostate cancers combined. While most people diagnosed with lung cancer will die within the first two years of diagnosis -- this has not changed in 10 years -- some people are cured. There are currently about 333,000 long-term survivors.

Chemotherapy is a good remedy for killing cancer cells -- and I hope every day that it did its job and killed all cancer cells that may have floated away from my original breast cancer tumor. But one not-so-good side effect of this good remedy is the beating that healthy cells take in the process of this life-saving treatment. It will be a red-letter day when chemotherapy can target only cancer cells, while leaving healthy cells unaffected. And this day may be a bit closer for patients in Taiwan who find they are in the early stages of relapse with nasopharynx cancer.

On Wednesday, National Taiwan University Hospital introduced a new high-tech laser procedure -- potassium-titanyl-phosphate or KPT -- to vaporize cancer cells. Doctors use a small endoscopic camera and easily manipulate the laser to precisely eliminate the cancer cells in the back of the nose and the soft roof of the mouth -- without harming healthy cells. The procedure takes roughly 90 minutes and requires a two-day stay in the hospital. This procedure should only be used in the early stages of relapse, though, and first-time cancer patients should still seek chemotherapy. And while those in later stages of relapse can still receive the treatment, it will only relieve discomfort without solving the problem.

To date, there have been 16 successful KPT treatments for this disease that about 1,000 people in Taiwan contract each year.